Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Non-Current Deferred Tax Liability (2020 - 2026)

Alvotech's (ALVO) quarterly Non-Current Deferred Tax Liability came in at $6.9 million in Q2 2026, up 242.7% on a YoY basis from $2.0 million in Q2 2025, and down 3.66% quarter-over-quarter from $7.2 million in Q1 2026.

Analysis

Alvotech (ALVO) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Non-Current Deferred Tax Liability for 7 consecutive years, with $6.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Deferred Tax Liability rose 242.7% year-over-year to $6.9 million; the trailing twelve-month figure through Jun 2026 stood at $6.9 million (up 242.7% YoY), and the FY2025 full-year result was $7.9 million, up 334.46% from the prior year.
  • Non-Current Deferred Tax Liability retreated to $6.9 million in Q2 2026 per ALVO's latest filing, from $7.2 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $7.9 million in Q4 2025 and bottomed at $45000.0 in Q2 2023.
  • Historically, Non-Current Deferred Tax Liability has averaged $2.9 million across 5 years, with a median of $1.7 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability sank 82.85% in 2023, then jumped 3316.98% in 2024.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $309000.0 in 2022, then tumbled by 82.85% to $53000.0 in 2023, then surged by 3316.98% to $1.8 million in 2024, then surged by 334.46% to $7.9 million in 2025, then dropped by 12.28% to $6.9 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $6.9 million, $7.2 million, and $7.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.90 Mn
Mar 31, 2026 7.16 Mn
Dec 31, 2025 7.87 Mn
Sep 30, 2025 7.54 Mn
Jun 30, 2025 2.01 Mn
Mar 31, 2025 2.06 Mn
Dec 31, 2024 1.81 Mn
Sep 30, 2024 1.54 Mn
Jun 30, 2024 1.39 Mn
Mar 31, 2024 1.61 Mn
Dec 31, 2023 53,000.00
Jun 30, 2023 45,000.00
Dec 31, 2022 309,000.00
Jun 30, 2022 141,000.00
Dec 31, 2021 150,000.00
Dec 31, 2020 217,000.00